Logout Lundbeck sites Contact Us
Significant improvements in GAD symptoms were seen from week 1 onwards in patients treated with escitalopram (10 mg/day) compared with placebo. Escitalopram (20mg/day) significantly reduced the risk of relapse compared with placebo.
References:
1. Davidson et al. Depress Anxiety 2004a;19(4):234-40
2. Allgulander et al. Poster presented at the 25th ADAA Conference, Seattle, Washington, 17-20 March 2005